Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Shenzhen Salubris Pharmaceuticals Co Ltd Announces FY 2012 Dividend Payment


Monday, 25 Mar 2013 08:00pm EDT 

SHENZHEN SALUBRIS PHARM CO., LTD. announced that it will use undistributed profits to pay a cash dividend of RMB 7 per 10 shares (pre-tax) and use additional paid-in capital to distribute five new shares for every 10 shares, to shareholders for fiscal year 2012. 

Company Quote

30.39
0.19 +0.63%
16 Apr 2014